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Disentangling the nature of the nicotine stimulus✩
Rick A. Bevins*, Scott T. Barrett, Robert J. Polewan, Steven T. Pittenger, Natashia Swalve,
and Sergios Charntikov
Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE 68588-0308, USA
Abstract
Learning involving interoceptive stimuli likely plays an important role in many diseases and
psychopathologies. Within this area, there has been extensive research investigating the
interoceptive stimulus effects of abused drugs. In this pursuit, behavioral pharmacologists have
taken advantage of what is known about learning processes and adapted the techniques to
investigate the behavioral and receptor mechanisms of drug stimuli. Of particular interest is the
nicotine stimulus and the use of the two-lever operant drug discrimination task and the Pavlovian
drug discriminated goal-tracking task. There is strong concordance between the two methods
when using “standard” testing protocols that minimize learning on test days. For example,
ABT-418, nornicotine, and varenicline all fully evoked nicotine-appropriate responding. Notably,
research from our laboratory with the discriminated goal-tracking task has used an alternative
testing protocol. This protocol assesses stimulus substitution based on how well extinction
learning using a non-nicotine ligand transfers back to the nicotine stimulus. These findings
challenge conclusions based on more “standard” testing procedures (e.g., ABT-418 is not nicotine-
like). As a starting point, we propose Thurstone scaling as a quantitative method for more
precisely comparing transfer of extinction across doses, experiments, and investigators. We close
with a discussion of future research directions and potential implications of the research for
understanding interoceptive stimuli.
Keywords
Drug discrimination; Extinction learning; Nornicotine; Pavlovian conditioning; Smoking;
Tobacco; Varenicline
1. Introduction
Human behavior is guided by stimuli outside the body (exteroceptive), as well as those
within the body (interoceptive). Take as an example a morning cup of hot coffee. The sight
of the mug on the table, the smoothness and warmth of the mug, and the aroma of the coffee
are considered exteroceptive stimuli. Such stimuli may make the person walk across the
room, sniff the coffee more deeply as she shifts to holding the mug by its handle before
taking a sip. Ingestion of this coffee then has interoceptive stimulus effects that can affect
behavior. These may include the warmth in the throat, the change in stomach acidity, and
the increased alertness induced by caffeine’s effects in the central nervous system. Like the
exteroceptive stimuli, these interoceptive stimuli are available to serve as a stimulus that can
enter in association with other stimuli in the environment. Such a learning history can
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change subsequent behavior evoked by these interoceptive stimuli (cf. Alessi et al., 2002;
Bevins and Murray, 2011).
The challenge for scientists is to develop methods for assessing learning involving these
interoceptive stimuli and to accurately characterize the nature of these stimuli. This mini-
review will describe a subset of methods that have been used to study the interoceptive
effects of drugs. We will focus on nicotine, a key addictive constituent of tobacco products,
and its interoceptive stimulus effect using rats. In the doing so, we will discuss some recent
disparate results that prompt us to think more deeply about the issues around how we
measure interoceptive stimuli and infer stimulus similarity and underlying receptor
mechanisms.
2. Interoceptive drug stimuli: training methods
Understanding how interoceptive stimuli guide an organism’s behavior has been a focus of
conditioning research since the pioneering studies of Ivan Pavlov (Pavlov and Anrep, 1927).
In fact, Pavlov coined the term “conditioned reflex”, currently adopted as “conditioned
response”, by observing and measuring the flow of gastric and intestinal fluids in dogs
anticipating reward (Pavlov and Anrep, 1927). Early interoceptive conditioning studies used
internal stimuli ranging from stomach irrigation, electric brain stimulation, and injected
ligands (Bykov, 1957; Doty, 1961; Cook et al., 1960; Pavlov and Anrep, 1927). Take as an
example Bykov’s work with water irrigation of the stomach as the interoceptive conditioned
stimulus (CS). Using dogs, this water irrigation CS was repeatedly paired with a bread or
meat powder unconditioned stimulus (US). Eventually, this interoceptive stimulation of the
stomach evoked an increase in salivation, as well as orientation and licking directed toward
the source of the US (Bykov, 1957).
A variety of methods to study interoceptive drug stimuli in animal models have evolved
from this early research. The most widely used is the two-lever operant drug discrimination
procedure. In this task, there are intermixed drug and no drug sessions. On a drug session
[e.g., 0.4 mg (base)/kg nicotine], rats are reinforced with food for pressing one of the levers
(say the right lever) under some schedule of reinforcement; left lever presses are not
reinforced on nicotine sessions. Conversely, on a no drug (saline) session, the opposite
contingency is in force; left lever presses reinforced and right lever presses under extinction.
Control of behavior by the interoceptive stimulus is demonstrated by greater than 80%
accuracy of lever pressing on the drug-appropriate lever under test conditions where the
reinforcer cannot serve as a signal for correct lever choice. For recent reviews of the nicotine
operant drug discrimination literature and the underlying neural processes mediating the
discriminative stimulus (SD) effects of nicotine, we refer the reader to Smith and Stolerman
(2009) and Wooters et al. (2009).
In our laboratory, we have used an alternative procedure to study the nicotine stimulus (e.g.,
Besheer et al., 2004; Murray et al., 2011; Wilkinson et al., 2006). In this particular task, we
use a Pavlovian drug discrimination procedure that differentially pairs the nicotine stimulus
(i.e., the CS) with an appetitive event such as sucrose delivery (i.e., the US). More
specifically, there are intermixed nicotine and saline sessions (see Fig. 1A). On nicotine
sessions, rats receive intermittent access to 4 s of sucrose (26%, w/v) in a 20-min session.
On saline sessions, no sucrose is available. Control of behavior by the nicotine CS is
evidenced by a differential increase in dipper entries [i.e., goal-tracking (Farwell and Ayres,
1979)] on nicotine sessions. Fig. 1B shows acquisition in rats trained under this protocol
(see caption for more detail). As can be seen, the discrimination is acquired quickly with a
robust goal-tracking conditioned response (CR) being maintained from sessions 5 to 14. For
a summary of the neuropharmacological and behavioral research using this Pavlovian drug
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discriminated goal-tracking task with a nicotine CS, we refer the reader to Bevins (2009)
and Wooters et al. (2009).
3. Inferring stimulus similarity from substitution tests
Pigeons reinforced to peck a yellowish-orange (580 nm) key will respond at a comparable
rate to wavelengths close to the training value. As the deviation increases, key pecking
decreases accordingly (Guttman and Kalish, 1956). A common inference from these
stimulus generalization (substitution) studies is that wavelength is a relevant stimulus
dimension controlling behavior, and that the extent of the difference in responding between
two wavelengths reflects their perceived similarity or difference of the stimuli being tested.
A similar approach is used in drug discrimination research. Once stimulus control of
behavior by the nicotine stimulus (SD or CS) is gained, then other ligands, often with at least
partially known receptor mechanisms, can be given in place of nicotine on test days. There
are several different methods for conducting substitution testing. One popular approach is to
make the test sessions much shorter (ca. 4 min) than the training sessions (ca. 20 min) and to
withhold the reinforcer. Another common method is to keep the test session similar to the
training sessions, except that responding on either lever is reinforced according to the
training schedule of reinforcement. The extent to which the test ligand evokes nicotine-
appropriate responding serves as the index of stimulus similarity. Both approaches are
successful. That is, they generate orderly and lawful dose–effect curves, they do not seem to
disrupt discrimination performance on intervening training session, and they can be
employed repeatedly over extended time periods (more than a year in rats). This suggests
that these approaches minimize what is learned during testing, thus not affecting the nature
of the drug stimulus under investigation.
Take as an example of substitution testing a recent study from our lab assessing a variety of
nicotinic acetylcholine agonists or partial agonist for their similarity to the nicotine CS
(Reichel et al., 2010). Once performance stabilized (cf. Fig. 1B), substitution testing began
in which rats were tested every fifth day given that the discrimination was maintained on the
intervening four training days. For each substitution test, the rat was pretreated with the test
ligand (ABT-418, varenicline, or nornicotine) at the prescribed time before being placed in
the chamber for a 4-min extinction test (no access to sucrose). Of particular interest for the
present report was the finding that the higher test doses of varenicline (Chantix®), ABT-418,
and nornicotine all evoked a goal-tracking CR statistically comparable to the nicotine CS
(Reichel et al., 2010). According to this method of assessing stimulus similarity, these
ligands, which differ in their binding at nicotinic acetylcholine receptor subtypes, are all
nicotine-like as they fully substitute for the nicotine CS. There is good concordance of these
findings with the operant drug discrimination task. ABT-418 (Damaj et al., 1995),
nornicotine (Goldberg et al., 1989), and varenicline (Jutkiewicz et al., 2011; Paterson et al.,
2010) fully substitute for the nicotine SD [see LeSage et al. (2009) and Smith et al. (2007)
for partial substitution with varenicline]. The inference of stimulus similarity from the
results of these substitution tests also comes with an inference of receptor mechanism. Take
as an example ABT-418 and varenicline. ABT-418 receptor specificity for nicotinic
acetylcholine receptor subunits is α4β2 > α3β4 > α3β2 > α7 (Hahan et al., 2003). For
varenicline it is α4β2 > α3β4 > α7 (Smith et al., 2007). The overlap suggests at least
involvement of receptors containing α4β2 and α3β4 subunits. The α7 is not included in this
list given that the α7 antagonist MLA does not block the goal-tracking CR evoked by the
nicotine CS (Struthers et al., 2009).
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4. Testing the inference of stimulus similarity
The known differences in receptor binding profile of nicotine versus ABT-418, nornicotine,
and varenicline made us wonder whether these differences were irrelevant to what is
ultimately perceived as the nicotine stimulus (Hahan et al., 2003; Middleton et al., 2007;
Papke et al., 2007; Smith et al., 2007). If this conclusion regarding irrelevance was true, then
we should be able to demonstrate stimulus similarity among the ligands in other situations
besides the brief substitution test (cf. Reichel et al., 2010). Namely, we were interested in
prolonged and repeated extinction sessions (see following paragraph). To test this idea, we
trained nicotine as a CS in the drug discriminated goal-tracking task described earlier.
Following acquisition of the discrimination, rats were treated with nicotine, saline, ABT
418, nornicotine, or varenicline for 6 consecutive 20-min extinction sessions (NB. each non-
nicotine ligand was actually assessed in a separate study with its own controls). If these non-
nicotine ligands are nicotine-like, then the extinction of the goal-tracking CR should follow
the same course for all but the saline-treated rats. The results, however, revealed
incongruities between the ‘typical’ substitution tests versus the repeated prolonged
extinction sessions. Recall that in the ‘typical’ substitution tests, nornicotine (3 mg/kg) and
varenicline (1 mg/kg) fully substituted for the nicotine CS. In contrast, these two ligands
only partially substituted for nicotine over repeated extinction sessions. That is, goal-
tracking was significantly lower than nicotine, but higher than saline across extinction. This
finding in the repeated extinction tests even held for a dose of nornicotine (1 mg/kg) and
varenicline (0.1 mg/kg) that only partially substituted for the nicotine CS in the ‘typical’
substitution tests. Surprisingly, pretreatment with ABT-418 evoked a partial CR only on the
first extinction session. On the remaining 5 extinction sessions, responding did not differ
from saline controls (Reichel et al., 2010). Thus, the conclusion regarding how nicotine-like
a ligand may be, and hence the inferred receptor mechanisms, shifts with the test used. As
soon as rats had a short history with non-reinforcement, ABT-418 no longer substituted (full
or partial) for the nicotine stimulus. Varenicline and nornicotine continued to evoke a partial
CR after this history of non-reinforcement.
After the last extinction test, we conducted a transfer test to assess whether extinction
learning with any of these non-nicotine ligands would generalize back to the nicotine CS
(Reichel et al., 2010). The day following extinction, all rats were tested with the training
dose of nicotine in a 20-min extinction session. Rats that received nicotine during extinction
showed significantly lower levels of conditioned responding during the transfer test than rats
who had received saline (i.e., no extinction, the CR was intact on this nicotine test).
ABT-418 (0.3 or 0.6 mg/kg) treatment during extinction had no effect on dipper entry rates
during the subsequent nicotine transfer test. Thus, the lack of responding in the extinction
phase predicted the lack of transfer of extinction learning back to the nicotine CS. However,
we observed partial transfer of extinction at both doses of varenicline (0.1 and 1.0 mg/kg)
and nornicotine (3.0 mg/kg). Nicotine-evoked conditioned responding was higher than rats
that had nicotine in the extinction phase, but lower than saline controls that did not receive
any extinction training. As with the repeated and prolonged extinction tests, the conclusions
regarding stimulus similarity with nicotine and its receptor mechanism differ from the
‘typical’ substitution tests used in the field. Although the results in the repeated extinction
tests parallel those in the transfer of extinction test in our published research (Reichel et al.,
2010), unpublished data with bupropion (Zyban®), an inhibitor of dopamine and
norepinephrine reuptake, as well as nicotinic antagonist (Dwoskin et al., 2006), suggest that
this relation does not always hold.
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5. A ruler for comparing ligands: Thurstone scaling
As briefly noted earlier, each non-nicotine ligand was tested in a separate experiment with
its own controls. Further, we have both planned and ongoing experiments using this transfer
of extinction test of stimulus similarity with other ligands. In order to better compare the
transfer of extinction results across experiments and between substitution ligands, we
employed Thurstone scaling to the data (Thurstone, 1927). Such scaling allows us to
examine how a history of non-reinforcement with the various ligands impacted the CR, via
comparison to the training nicotine CS along a common continuum with saline and the
training dose of nicotine as the endpoints. To calculate the endpoints for the scale, we used
the average data from the nicotine and saline conditions across all three transfer of
extinction experiments in order to generate their most reliable estimates of this continuum
across time (see Table 1). The scale was constructed using the following calculation of
effect size:
where X represents average observed dipper entries under the condition of interest (nicotine,
saline, or substitution ligand), S represents the average observed dipper entries under the
saline condition, and σ represents the pooled standard deviation between nicotine and saline
conditions. This approach allows for comparison between substitution ligands using
comparative effect size with the pooled standard deviation between nicotine and saline
conditions as the unit. Note that this transformation places the value assigned to saline at the
origin and the value now assigned to nicotine as the scaled discriminability of these two
standards from one another (Peter Killeen, personal communication). Fig. 2 shows the
scaled dipper entries (conditioned responding) for the non-nicotine ligands examined in the
transfer of extinction tests by Reichel et al. (2010). We are excited about the possibilities
afforded by this and related approaches (see next section). At least for the transfer of
extinction test data, we can move away from the ambiguous language that classifies a ligand
into one of 3 categories—full, partial, or no substitution—to a quantitative measure based on
a common and empirically established ruler.
A percent substitution measure such as percentage of CR in the discriminated goal-tracking
task or percent drug-appropriate responding in the two-lever task (see earlier) could also
provide this ruler. However, the Thurstone scaling method more precisely defines the
endpoints of this ruler than a percent substitution value. For example, one common way to
calculate percent value is to declare the absolute rates of response under nicotine conditions
as 100%, and no responding as 0%. This approach is problematic because it is rare in drug
discrimination research to observe no responding under saline conditions (cf. Fig. 1B).
Alternatively, a second method to calculate a percent value is to declare the difference
between nicotine and saline conditions as the upper endpoint (100%), and then compare
substitution ligands by calculating a difference from saline conditions and dividing that by
the nicotine difference score. Although this method is similar to Thurstone scaling, only the
latter approach scales these difference scores by the pooled standard deviation for the
endpoints. This scaling addresses issues that might arise from differences in variability
across testing conditions within or between experiments by normalizing the scale into units
of relative effect size.
6. Considerations and future directions
Morrison and Stephenson (1969) were the first to establish that nicotine could serve as a
stimulus that could come to control behavior. Since this seminal paper, many investigators
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have adopted the two-lever operant drug discrimination task (see earlier) to assess receptor
mechanisms and potential pharmacotherapies [see Smith and Stolerman (2009) and Wooters
et al. (2009) for reviews]. Our recent research on transfer of extinction learning prompts
several questions regarding what different approaches might tell us about the nicotine
stimulus. In the discriminated goal-tracking task with the nicotine CS, a standard 4-min
generalization test with some other ligand does not necessarily reflect performance in the
face of continued non-reinforcement (repeated extinction tests), nor does it inform us as to
how this non-reinforcement will subsequently affect behavior evoked by the nicotine CS. At
present, there has been no test of whether similar dissociations would occur in the two-lever
drug discrimination task. For example, ABT-418 prompts full substitution for nicotine-
appropriate responding in brief generalization tests (Damaj et al., 1995); a result similar to
the nicotine CS (Reichel et al., 2010). Would ABT-418 continue to prompt discriminated
lever pressing at a level comparable to the training dose of nicotine over repeated extinction
sessions or, would nicotine-appropriate responding more quickly decrease and/or switch
quickly to the saline (no-drug) lever? The latter result would be consistent with our finding
that ABT-418 is not nicotine-like once the rat has a brief history of non-reinforcement
(Reichel et al., 2010). If ABT-418 was similar to nicotine in extinction for the two-lever
task, then the question becomes whether that extinction learning influences stimulus control
by the nicotine SD. Of course, any attempt at an answer to these questions would be pure
speculation on our part.
The generality of these findings to other variants of the drug discriminated goal-tracking
task would also be of interest. For example, in a feature positive occasion setting version of
the task, there are intermixed saline and nicotine sessions. On nicotine sessions, a discrete
stimulus (e.g., 15-s illumination of a cue light) is followed by 4-s access to sucrose. On
saline sessions, the same 15-s light is presented, but no sucrose is delivered. Thus, nicotine
occasions when the light presentation will be reinforced. To test transfer of extinction in this
situation, varenicline, as an example, would replace nicotine and there would be several
sessions of presenting the lights without sucrose before retesting nicotine. Would the partial
substitution of varenicline seen in the transfer test for the nicotine CS hold for the nicotine
feature positive modulator? Given that the nature of the associative learning differs for CSs
versus occasion setters, including drug stimuli in these roles (cf. Palmatier and Bevins, 2007,
2008), there may well be differences in the substitution pattern of different ligands in the
repeated extinction versus the transfer of extinction learning tests. As with the two-lever
procedure, answers to these questions and hence implications for understanding the nature of
the nicotine stimulus will have to await further research.
As noted earlier, the two-lever operant drug discrimination task has been widely used by
researchers with the goal of understanding the nature of the nicotine stimulus and potential
targets for medication development. As a result of these efforts, we know quite a bit about
the nicotine SD and its receptor mechanisms (Smith and Stolerman, 2009; Wooters et al.,
2009). Our recent findings regarding repeated extinction and transfer of extinction, along
with questions regarding potential generality of such findings across different drug
discrimination tasks, prompt us to reflect on the relation between how stimulus substitution
is measured and how these findings will inform treatment and drug development. Does the
widely used brief generalization test tell us about a mechanism that is engaged in the
addiction process that differs from the transfer of extinction tests? Intuitively, the answer
would seem to be yes. The former test is explicitly designed to test for nicotine-like
responding in a situation that minimizes the opportunity for new learning. The latter test
does just the opposite. The assessment of stimulus similarity in the transfer of extinction test
is based on how well learning regarding non-reinforcement generalizes back to the training
stimulus.
Bevins et al. Page 6
Behav Processes. Author manuscript; available in PMC 2013 May 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Such reflection also makes us wonder which, if any, of the methods for assessing the nature
of the nicotine stimulus and its receptor mechanisms would more readily translate to
addiction treatment or better predict targets for medication development. Alternatively,
perhaps an approach that measures stimulus substitution across a range of protocols,
including approaches not mentioned here, would be better than only one assay. This, of
course, would be a large undertaking given the need to train separate animals in each
protocol. To this end, a standardized metric that combines these scores in a manner that
allows comparison of composite scores across experiments and investigators will be
invaluable. In this report, we have made the first step toward this end by using Thur-stone
scaling to compare the transfer of extinction findings across the experiments evaluating
ABT-418, nornicotine, and varenicline. Up to now, we merely referred to their substitution
for nicotine in the transfer test using the imprecise terms of partial (nornicotine, varenicline)
to none (ABT-418). We now have a value that allows us to more precisely compare these
ligands at various doses within and across experiments (see Fig. 2 and Table 1). Future
efforts will obviously need to build toward a scaled metric for each method/measure of
stimulus substitution, and then determine the utility of developing a composite score.
In an earlier paper, we used the expression “associative substitution” (vs. stimulus
substitution) to refer to the approach of using learning processes to assess the overlap in the
stimulus effects of a ligand with nicotine (Wilkinson et al., 2010, p. 826). Extinction
learning, of course, is just one form of associative learning that could be used to this end.
The list is long, interesting, and completely unexplored. Take as an example the CS
preexposure effect [latent inhibition; e.g., Ayres et al., 1992; Lubow, 1973]. Procedurally, in
a CS preexposure experiment, the animal first receives repeated nonreinforced exposure to
CS. Subsequently, this CS is then paired with the US. The CS preexposure effect is
evidenced by slowed acquisition of a CR relative to controls. Translating this description
into an experiment examining associative substitution seems straightforward. The first phase
would involve repeated administration of the ligand of interest (e.g., nornicotine) in the
conditioning chamber without access to the sucrose US. In the second phase, the primary
group of interest would be one that then received nicotine trained as a CS. That is,
intermixed nicotine and saline sessions with nicotine sessions including intermittent
reinforcement. The extent to which the expression of the goal-tracking CR was delayed
relative to controls would serve as the measure of stimulus similarity between the
preexposed ligand and nicotine.
Although this hypothetical CS preexposure experiment is simple in description, one of
several challenges of working with drug stimuli (whether as a US or a CS) is the dynamic
nature of these complex stimuli (see Bevins and Murray, 2011). Take as an example
nornicotine. Preexposure to nornicotine alters the behavioral and neurobiological impact of
nicotine (e.g., Dwoskin et al., 1999; Papke et al., 2007). Thus, in the conditioning phase of
the hypothetical preexposure experiment, the nicotine CS may not be the same stimulus as
that in control conditions that did not receive nornicotine preexposure. This alternation may
mean that diminished acquisition occurred for a reason different from that hypothesized for
the CS preexposure effect involving exteroceptive stimuli (Lubow and Weiner, 2010). For
this matter, acquisition may be quickened if the neurobiological effects of nornicotine
preexposure enhanced the salience or perceptibility of the nicotine stimulus. Either result
would be quite interesting and would point to particular individual histories that slow or
accelerate processes related, in this case, to chronic tobacco use and addiction.
7. Closing reflections
In general, we hope this brief review has generated an increased appreciation for the study
of interoceptive stimuli and related behavioral and neural processes. More specifically, we
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also hope the reader leaves with an understanding that disentangling the nature of the
nicotine stimulus (or any drug stimulus for that matter) may not be as simple as implied by
the vast literature on drug discrimination [cf. Fig. 7.2 in Bevins (2009)]. This point is not
meant to diminish the importance of the nicotine drug discrimination research over the past
30+ years. In fact, our point is just the opposite. We believe it is critically important to
understand the nature of interoceptive stimuli. As such, the research community should
bring to bear all of the tools that behavioral pharmacology and learning theory has to
provide. By doing so, the field will acquire a deeper understanding of basic processes that
could provide new molecular targets for drug development and/or improved behavioral
approaches for many of the important public health problems. The present report had
focused on drug addiction, with an emphasis on nicotine [see Bevins and Murray (2011) for
a more detailed review of interoceptive stimuli and drug abuse]. However, interoceptive
stimuli have been implicated in such health issues as treatment of cancer (Meagher, 2010),
cardiovascular disease (Koroboki et al., 2010), chronic pain (De Peuter et al., 2011),
schizophrenia (Wylie and Tregellas, 2010), impaired cognition in aging (Fadel and Burk,
2010), anxiety disorders (Domschke et al., 2010), depression (Paulus and Stein, 2010),
eating disorders (Oldershaw et al., 2011; Davidson, 1993), and obesity (Davidson, 1993).
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Fig. 1.
(A) A cartooned version of the standard discriminated goal-tracking protocol used in the
laboratory with 0.4 mg (base)/kg nicotine as the CS. As indicated in this graphic, the
measure of conditioning comes from the time before the first sucrose delivery on nicotine
sessions or an equivalent time in saline session. Given that this time varies across sessions,
we use rate of dipper entries per second as the primary dependent measure. (B) Acquisition
data from rats in Experiment 5 (transfer of extinction with varenicline) from Reichel et al.
(2010); these data were not reported in that paper.
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Fig. 2.
Graphical representation of comparative effect sizes between substitution ligands along a
Thurstone scale for the transfer of extinction tests. The range of the scale represents the
scaled discriminability between saline and 0.4 mg/kg nicotine on the transfer of extinction
tests. Therefore, points on the leftmost end of scale may be characterized as “less nicotine-
like” and points on the rightmost end of the scale may be characterized as “more nicotine-
like”. Points on the scale represent the group means for each substitution ligand. Each tick
denotes 0.2 units, ABT denotes ABT-418, N denotes nornicotine, and V denotes varenicline.
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Table 1
Dipper entries and Thurstone scaling values.
Test ligand Dipper entries Scaled entries
Saline 138 ± 6.09 0.00 ± 0.00
0.4 Nicotine 79.9 ± 3.62 −3.65 ± 0.522
0.3 ABT-418 145 ± 16.7 0.451 ± 1.20
0.6 ABT-418 146 ± 10.7 0.495 ± 0.798
0.1 Varenicline 94.6 ± 10.4 −2.72 ± 0.663
1.0 Varenicline 102 ± 7.57 −2.24 ± 0.553
1.0 Nornicotine 113 ± 8.71 −1.58 ± 0.626
3.0 Nornicotine 108 ± 9.43 −1.85 ± 0.646
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